Related Experiment Video
Updated: Apr 26, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
1.0K
Malignancy and mortality of colorectal polyps
Summary
Endoscopic polypectomy significantly reduces the risk of colorectal cancer recurrence in high-risk patients. Regular surveillance is crucial for managing benign polyps and preventing malignancy.
Area of Science:
- Gastroenterology
- Oncology
- Public Health
Background:
- Colorectal polyps are common, with a subset progressing to malignancy.
- High-risk populations require effective surveillance and management strategies.
Purpose of the Study:
- To assess morbidity and mortality rates following endoscopic polypectomy for colorectal polyps over an 8-year period.
- To evaluate the impact of polypectomy on colorectal cancer incidence and recurrence in a high-risk population.
Main Methods:
- A cohort of 77 subjects with benign neoplasms was studied, comparing groups with and without polypectomy.
- Recurrence rates of benign and malignant neoplasms were tracked over 5 and 8 years.
- Immunohistochemical staining for p53 and PCNA was used to evaluate malignancy.
Main Results:
- The 5-year cumulative incidence of colorectal cancer was 18.1% in the benign neoplasm group versus 5% in the no-neoplasm group.
- Polypectomy in benign neoplasms was associated with a lower 5-year malignancy rate (12%) compared to no polypectomy (33.3%).
- The 8-year mortality rate was 0% in the no-neoplasm group, 40% in the recurrent benign polyps group, and 100% in the malignant neoplasm group.
Conclusions:
- High recurrence rates of benign colorectal neoplasms necessitate ongoing surveillance.
- Individuals with a history of benign colorectal neoplasms face an increased incidence of colorectal cancer.
- Interventions and surveillance strategies are vital for reducing morbidity associated with colorectal neoplasms in high-risk individuals.
Related Concept Videos
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer Survival Analysis
857
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
857
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Cancer
51.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.4K

